Outcome of T‐cell/histiocyte‐rich large B‐cell lymphoma—A Danish nationwide matched cohort study

Documenti analoghi

• Effectiveness of rituximab and biosimilar rituximab in untreated diffuse large B‐cell lymphoma, a Danish population‐based analysis
  di: Amal Haujir, et al.
  Pubblicazione: (2025)
• Late infections after high‐dose therapy and autologous stem cell transplantation for lymphoma: A Danish population‐based study
  di: Freja Tang Severinsen, et al.
  Pubblicazione: (2025)
• Effectiveness of R‐CHOP versus R‐CHOEP for treatment of young patients with high‐risk diffuse large B‐cell lymphoma: A Danish observational population‐based study
  di: Rasmus Rask Kragh Jørgensen, et al.
  Pubblicazione: (2024)
• Revisiting beta‐2 microglobulin as a prognostic marker in diffuse large B‐cell lymphoma
  di: Jelena Jelicic, et al.
  Pubblicazione: (2024)
• Secondary central nervous system lymphoma (SCNSL) in mantle cell lymphoma (MCL): Characteristics and risk factors in a Danish nationwide population‐based study
  di: Trine Trab, et al.
  Pubblicazione: (2025)